Boston Scientificvs.ResMed
BSX vs RMD · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Boston Scientific is about 2.2× larger than ResMed by market cap; year to date, ResMed leads (−15.4% vs −53.0%).
Side by side
| BSX | RMD | |
|---|---|---|
| Market cap | $66.5B | $29.8B |
| Price | $44.77 | $203.87 |
| Today | −0.5% | −2.2% |
| Return YTD | −53.0% | −15.4% |
| Return 1Y | −56.9% | −21.0% |
| P/E | 18.7 | 19.6 |
| P/S | 3.2 | 5.4 |
| P/B | 2.6 | 4.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →More comparisons in Medtech & devices
See where BSX and RMD sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →